In a patient with a percutaneous trans‑hepatic biliary drain for biliary obstruction, what does yellow versus green drainage fluid indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bile Color via PTBD Drain: Clinical Significance

Yellow or green bile drainage from a PTBD catheter indicates normal bile flow and successful biliary decompression, confirming patency of the biliary system. Both colors represent physiologically normal bile containing bilirubin and bile salts, with the color variation reflecting concentration and oxidation state rather than pathology 1, 2.

Normal Bile Characteristics

  • Yellow to green drainage is the expected finding when a PTBD catheter successfully decompresses an obstructed biliary system 2, 3.
  • The color variation between yellow and green reflects normal bile composition, with both indicating adequate biliary lipid content (cholesterol, phospholipids, bile salts) and bilirubin 2.
  • Green coloration results from oxidation of bilirubin to biliverdin when bile is exposed to air in the drainage system 2.
  • Normal bile volume through PTBD typically ranges from 200-800 mL per day, though this varies with the degree of obstruction relief 3, 4.

Abnormal Drainage Findings to Recognize

  • Clear, colorless fluid ("white bile") indicates complete biliary obstruction upstream from the catheter, representing mucus secretion from bile duct epithelium without bilirubin 2.
  • White bile has lower biliary lipids, alkaline pH, and similar electrolyte composition to normal bile, but lacks the pigmented components 2.
  • Clear colorless fluid may appear intermittently (alternating daily with normal yellow bile) even when cholangiography confirms biliary patency, likely representing gallbladder epithelial secretions rather than true bile 2.
  • Bloody or serosanguineous drainage suggests hemobilia, a complication requiring evaluation for vascular injury, pseudoaneurysm, or catheter malposition 5, 1.
  • Purulent or cloudy drainage indicates cholangitis or infected bile, requiring urgent culture and antibiotic adjustment 5, 6.

Clinical Implications for Management

  • Yellow or green drainage confirms successful decompression and indicates the catheter is functioning appropriately within the biliary tree 1, 3.
  • Monitor daily drainage volume and character; decreasing output or color change to clear may signal catheter occlusion or malposition requiring cholangiography 1, 4.
  • Persistent clear drainage despite confirmed biliary patency on cholangiography (appearing average 12 days post-placement, <60 mL/day) is a benign finding not requiring intervention 2.
  • Cholangiography should be performed 2-3 weeks after PTBD placement before catheter removal to confirm biliary tree patency and absence of residual obstruction 5, 1.

Common Pitfalls to Avoid

  • Do not assume clear drainage always means complete obstruction; it may represent normal gallbladder epithelial secretions in patients with confirmed biliary patency 2.
  • Do not remove the catheter based on drainage color alone; always perform cholangiography to document cystic duct patency and absence of leak before removal 5, 1.
  • Do not ignore sudden changes in drainage character (bloody, purulent, or cessation of flow), as these indicate complications requiring immediate imaging and intervention 5, 1, 4.
  • Recognize that drainage volume naturally decreases as biliary edema resolves and internal drainage improves, but complete cessation warrants catheter evaluation 3, 4.

References

Guideline

Percutaneous Transhepatic Cholangiography Drainage

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Percutaneous transhepatic biliary drainage: a review.

Critical reviews in diagnostic imaging, 1990

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Severe Cholangitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

In a patient with a percutaneous trans‑hepatic biliary drainage (PTBD) catheter, can the color of the drained bile (green, dark‑green, or white) be used to determine if the bile is infected?
In a patient with a percutaneous trans‑hepatic biliary drainage catheter, does the color of the drained bile (green, dark‑green, or clear/white) reliably indicate infection?
In a patient with a percutaneous trans‑hepatic biliary drainage (PTBD) catheter who suddenly notices clear/white bile drainage, does the white bile indicate a long‑standing obstruction?
Can percutaneous trans‑hepatic biliary drainage be internalized after 48–72 hours?
Can percutaneous trans‑hepatic biliary drainage be internalized in a pancreatic cancer patient after only 48–72 hours?
What is the appropriate management for a 35-year-old man with persistently elevated total cholesterol, low‑density lipoprotein cholesterol (LDL‑C), and triglycerides?
How should hydroquinone be used (concentration, application frequency, duration, and sun protection) as first‑line treatment for dark spots in an adult without hypersensitivity, pregnancy, lactation, or active skin infection?
With a fasting triglyceride level of 265 mg/dL, should I start fenofibrate?
How should I treat a 55-year-old man with a total testosterone of 245 ng/dL?
How should vaginismus be managed in a reproductive‑age woman who has never had intercourse and has a history of trauma, anxiety, or chronic pelvic pain?
Is Jardiance (empagliflozin) contraindicated in a patient with a history of bladder cancer who is currently in remission and has no hematuria?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.